BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

261 related articles for article (PubMed ID: 32895527)

  • 1. Anthrax lethal factor cleaves regulatory subunits of phosphoinositide-3 kinase to contribute to toxin lethality.
    Mendenhall MA; Liu S; Portley MK; O'Mard D; Fattah R; Szabo R; Bugge TH; Khillan JS; Leppla SH; Moayeri M
    Nat Microbiol; 2020 Dec; 5(12):1464-1471. PubMed ID: 32895527
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The anthrax lethal factor and its MAPK kinase-specific metalloprotease activity.
    Tonello F; Montecucco C
    Mol Aspects Med; 2009 Dec; 30(6):431-8. PubMed ID: 19665472
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anthrax protective antigen cleavage and clearance from the blood of mice and rats.
    Moayeri M; Wiggins JF; Leppla SH
    Infect Immun; 2007 Nov; 75(11):5175-84. PubMed ID: 17724066
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quantitative Determination of Lethal Toxin Proteins in Culture Supernatant of Human Live Anthrax Vaccine Bacillus anthracis A16R.
    Zai X; Zhang J; Liu J; Liu J; Li L; Yin Y; Fu L; Xu J; Chen W
    Toxins (Basel); 2016 Feb; 8(3):. PubMed ID: 26927174
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Exceptionally Selective Substrate Targeting by the Metalloprotease Anthrax Lethal Factor.
    Turk BE
    Adv Exp Med Biol; 2019; 1111():189-203. PubMed ID: 30267305
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anthrax toxin.
    Bhatnagar R; Batra S
    Crit Rev Microbiol; 2001; 27(3):167-200. PubMed ID: 11596878
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Consequences and utility of the zinc-dependent metalloprotease activity of anthrax lethal toxin.
    Bromberg-White J; Lee CS; Duesbery N
    Toxins (Basel); 2010 May; 2(5):1038-53. PubMed ID: 22069624
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anthrax lethal factor inhibition.
    Shoop WL; Xiong Y; Wiltsie J; Woods A; Guo J; Pivnichny JV; Felcetto T; Michael BF; Bansal A; Cummings RT; Cunningham BR; Friedlander AM; Douglas CM; Patel SB; Wisniewski D; Scapin G; Salowe SP; Zaller DM; Chapman KT; Scolnick EM; Schmatz DM; Bartizal K; MacCoss M; Hermes JD
    Proc Natl Acad Sci U S A; 2005 May; 102(22):7958-63. PubMed ID: 15911756
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anthrax lethal factor cleaves mouse nlrp1b in both toxin-sensitive and toxin-resistant macrophages.
    Hellmich KA; Levinsohn JL; Fattah R; Newman ZL; Maier N; Sastalla I; Liu S; Leppla SH; Moayeri M
    PLoS One; 2012; 7(11):e49741. PubMed ID: 23152930
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The receptors that mediate the direct lethality of anthrax toxin.
    Liu S; Zhang Y; Hoover B; Leppla SH
    Toxins (Basel); 2012 Dec; 5(1):1-8. PubMed ID: 23271637
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anthrax lethal factor inhibitors as potential countermeasure of the infection.
    Kumar BV; Malik S; Grandhi P; Dayam R; Sarma JA
    Curr Top Med Chem; 2014; 14(17):1977-89. PubMed ID: 25262802
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bacillus anthracis: a multi-faceted role for anthrax lethal toxin in thwarting host immune defenses.
    Xu L; Frucht DM
    Int J Biochem Cell Biol; 2007; 39(1):20-4. PubMed ID: 17008119
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of a Substrate-selective Exosite within the Metalloproteinase Anthrax Lethal Factor.
    Goldberg AB; Cho E; Miller CJ; Lou HJ; Turk BE
    J Biol Chem; 2017 Jan; 292(3):814-825. PubMed ID: 27909054
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Proteolytic inactivation of MAP-kinase-kinase by anthrax lethal factor.
    Duesbery NS; Webb CP; Leppla SH; Gordon VM; Klimpel KR; Copeland TD; Ahn NG; Oskarsson MK; Fukasawa K; Paull KD; Vande Woude GF
    Science; 1998 May; 280(5364):734-7. PubMed ID: 9563949
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Computational insights into the interaction of the anthrax lethal factor with the N-terminal region of its substrates.
    Joshi M; Ebalunode JO; Briggs JM
    Proteins; 2009 May; 75(2):323-35. PubMed ID: 18831046
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Insights into the anthrax lethal factor-substrate interaction and selectivity using docking and molecular dynamics simulations.
    Dalkas GA; Papakyriakou A; Vlamis-Gardikas A; Spyroulias GA
    Protein Sci; 2009 Aug; 18(8):1774-85. PubMed ID: 19585464
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Purified Bacillus anthracis lethal toxin complex formed in vitro and during infection exhibits functional and biological activity.
    Panchal RG; Halverson KM; Ribot W; Lane D; Kenny T; Abshire TG; Ezzell JW; Hoover TA; Powell B; Little S; Kasianowicz JJ; Bavari S
    J Biol Chem; 2005 Mar; 280(11):10834-9. PubMed ID: 15644338
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Purification and biophysical characterization of the core protease domain of anthrax lethal factor.
    Gkazonis PV; Dalkas GA; Chasapis CT; Vlamis-Gardikas A; Bentrop D; Spyroulias GA
    Biochem Biophys Res Commun; 2010 Jun; 396(3):643-7. PubMed ID: 20438702
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of toxin functional domains in anthrax pathogenesis.
    Brossier F; Weber-Levy M; Mock M; Sirard JC
    Infect Immun; 2000 Apr; 68(4):1781-6. PubMed ID: 10722564
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effects of anthrax lethal toxin on host barrier function.
    Xie T; Auth RD; Frucht DM
    Toxins (Basel); 2011 Jun; 3(6):591-607. PubMed ID: 22069727
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.